BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹288 Cr | ₹236 Cr | ₹174 Cr | ₹141 Cr | ₹91 Cr |
What is the latest Total Expenditure of BETA DRUGS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹174 Cr |
| Mar2022 | ₹141 Cr |
| Mar2021 | ₹91 Cr |
How is Total Expenditure of BETA DRUGS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | 22.08 | |
| Mar2024 | ₹236 Cr | 35.48 | |
| Mar2023 | ₹174 Cr | 23.27 | |
| Mar2022 | ₹141 Cr | 54.46 | |
| Mar2021 | ₹91 Cr | - | |
Compare Total Expenditure of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,478.9 Cr | -1.9% | 2.2% | 26.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -1.9% |
2.2% |
26.3% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses